Revvity | PKI - 普通股股本



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.34B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


普通股股本 更改 日
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 133K 2026-03
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Celltrion KRW 218.61M 162.21K 2025-12
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 0 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Illumina USD 151.91M 893K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 82.3M 100K 2026-03
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pharma Mar EUR 17.36M 0 2026-03
Qiagen NV USD 216.56M 284.67K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 0 2025-12
Repligen USD 56.4M 74K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Tilray USD 116.52M 5.01M 2025-09
Waters USD 98.17M 89K 2026-03
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03